Doctors Nova Scotia joins voices opposed to expanding booze sales in N.S.
It's a move that Doctors Nova Scotia fears will cause significantly more harm than good.
In June, 14 physicians who specialize in addiction medicine wrote an open letter to Finance Minister John Lohr, whose department is overseeing the process, saying alcohol already causes more than 500 deaths a year in Nova Scotia. Now, those doctors have the backing of the provincial organization that advocates for physicians.
Dr. Shelly McNeil, president of Doctors Nova Scotia, sent an email to members this week saying they are unequivocally opposed to expanding the availability of alcohol.
"We are imploring decision makers to think about it not just in the immediate increase in revenues, but also in the long-term costs in the system," she told CBC News.
"There's lots of evidence of the harms that come from this kind of policy shift."
Representatives from breweries and wineries say they participated in the consultations.
There were submissions from organizations who support the move, including the Retail Council of Canada, which argues that the sales will help stores that are losing business to online shopping.
The Canadian Federation of Independent Business is also for the change. It recommends allowing the sale of beverages that do not exceed 7.1 per cent alcohol by volume in convenience and grocery stores and opening those rules to all small businesses, not just large retailers.
Ontario expanded alcohol sales to smaller stores last year while setting limits on the volume of alcohol.
But McNeil said Ontario's health-care system is already seeing the downside to greater access, referring to a 17 per cent increase in hospital visits connected to alcohol.
A similar increase in Nova Scotia would mean 7,600 extra visits to the emergency department a year, she said.
"In an already overburdened system, we can't afford to have our emergency volumes go up that much and we can't afford the harms that come to people that lead them to the emergency department."
In Nova Scotia, alcohol is sold mainly at NSLC stores, agency stores in rural communities, four private stores in the Halifax area and sites owned by breweries, distilleries and wineries.
McNeil said one of her concerns lies with expansion to locations with less regulation, where teens would be more likely to be able to find a way to buy booze.
She said research shows alcohol can lead to increased rates of nine cancers, cardiovascular disease and chronic illnesses.
She is also worried about societal issues, pointing to intimate partner violence, which politicians in the provincial legislature declared in September 2024 to be an epidemic in Nova Scotia, and drinking and driving.
She said Doctors Nova Scotia has been happy with the Progressive Conservative government's work on health care to date but fears a decision in favour of expanding alcohol sales could undermine that work.
"We really worry that this will take a bite out of the progress that has been made."
McNeil said Doctors Nova Scotia made its submission in writing as part of the consultations, but she's urging policymakers to reach out and speak to physicians directly.
The Finance Department said in a statement that it is reviewing input from the consultations and it will determine the next steps. It won't say when Nova Scotians might hear an update.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
27 minutes ago
- Globe and Mail
As cancer rates increase for younger women, many choose to work during treatment
Sarah Mitchell, 44, was working full-time and going to school when she was diagnosed with breast cancer last fall. The single mother of two kids aged 8 and 10 dropped out of school right away, but decided to continue working through her six-month period of chemotherapy, which ended in March of this year. 'Part of it was that I needed some money to make ends meet,' she says, adding that housing costs in Victoria, where she lives, are very high and 'as a single income household, things are tight.' There are sickness benefits available to individuals facing cancer through federal Employment Insurance (EI), but they only cover 55 per cent of earnings up to a maximum of $695 a week, for 26 weeks. 'It's better than nothing, but it's not really enough to live on as a family of three,' Ms. Mitchell says. (Long-term disability benefits through Ms. Mitchell's employer wouldn't have kicked in until the EI benefits ran out, at 67 per cent of her salary.) Money wasn't the only reason Ms. Mitchell wanted to stay on the job. She says work was a huge help in keeping her mood in check. 'When you're not feeling well, you can focus on how you're not feeling well,' says Ms. Mitchell, who also continued to co-parent for her usual 50 per cent of the time. 'I needed to take my focus outside of myself.' Ms. Mitchell works in finance at a company that does leadership training, and says it helped that her employer was understanding on days she wasn't feeling well. She was able to work from home so she could do tasks from bed if she felt the need. 'I was just doing the bare bones of my job description [through chemo],' says Ms. Mitchell, who is now cancer-free but still feeling the effects of chemotherapy. 'Certain days after treatment that were just horrible,' she says, so 'If I needed a day [off]… I wouldn't work those days.' According to the Canadian Cancer Society, rates of cancer are higher for women than men among people under age 60. The sharpest rise in diagnosis rates is among women under 50, says Dr. Roochi Arora, a medical oncologist at Humber River Hospital in Toronto. A 2024 study out of the University of Ottawa examining Canadian data from the past 35 years showed an increase in rates of breast cancer diagnoses among women in their 20s, 30s and 40s. Dr. Arora, who says the majority of her patients are facing breast cancer, notes women are increasingly choosing to work during treatment. Some work to maintain normalcy and to avoid losing ground in their careers. Some work for monetary reasons and to maintain their work-provided health benefits at such a crucial time. 'Dual income is increasingly necessary in households, and many women have thriving careers they want to remain connected to even when going through cancer treatment.' Balancing a career and cancer at the same time is possible, she adds, but it helps if one plans ahead, sets realistic expectations and has job flexibility. Many patients' expenses go up when they get cancer, due to what Dr. Arora calls 'hidden costs' associated with dealing with an illness. They may need more help with their kids. They may have to pay for parking at hospitals on a weekly or bi-weekly basis. Some patients must pay for certain medications out-of-pocket as well. 'I can't tell you how many people are saying [that] EI barely covers anything,' she says. Hiding cancer while on the job Fear of loss of income or career repercussions may drive individuals living with cancer to conceal their condition and treatment from their employers. A 2023 study out of Memorial University in St. John's found that one in four of respondents – residents of Newfoundland and Labrador with a history of cancer – reported stigmatization due to their cancer history. A smaller number, one in seven respondents, said they had been discriminated against because of their cancer history. The study's authors said the most common sources contributing to those experiences were friends, insurance and financial companies and workplaces. Janice (who requested her last name be withheld due to fear of career repercussions) is a woman in her 60s living in the Greater Toronto Area. When Janice was diagnosed with breast cancer last year, she had breast-removal and reconstruction surgery without radiation or chemotherapy. When Janice was offered a new job shortly afterward, she took it, but decided not to disclose her cancer, even after she developed a 'massive infection' around her breast implant. She says her decision was partly because of a termination from a previous job that she attributed to ageism. Janice, who works in sales as an account manager, decided to keep working while hiding a vacuum dressing in her clothing – a contraption with a battery pack that covers the infected area and is attached to a pump with a hose. She said her device occasionally made sounds that she would disguise with a fake cough. 'I don't want the people I work with to change the way they look at me, the way they view me,' says Janice. 'It's my story.' If individuals want to continue working through cancer treatment, Dr. Arora says there are strategies they can try to help keep things manageable: Organizations can also help employees who are going through cancer better manage their lives, Dr. Arora adds. She recommends that employers be flexible about where and when an employee works, when possible, and consider lightening their employee's workload. Organizations should also offer all employees a benefits package that includes paid leave for illness. Interested in more perspectives about women in the workplace? Find all stories on The Globe Women's Collective hub here, and subscribe to the new Women and Work newsletter here. Have feedback? Email us at GWC@
National Post
27 minutes ago
- National Post
Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025
Article content LEXINGTON, Mass. — Agenus Inc. ('Agenus') (Nasdaq: AGEN), a leader in immuno-oncology, today announced that the Company will host a virtual Stakeholder Briefing on August 27, 2025 at 4:00 p.m. ET. The event will feature presentations from senior management and industry thought leaders, offering insights into transformative developments that could shape the future of cancer treatment. The agenda includes a strategic and financial overview, achievements tied to the Zydus partnership closing, patient needs fueling interest in colorectal cancer (CRC) studies, recent data from the botensilimab (BOT) and balstilimab (BAL) program, and an overview of the Phase 3 BATTMAN study in metastatic CRC—plus highlights of upcoming milestones and potential breakthroughs in immuno-oncology. The session will conclude with a live Q&A. Article content Speakers to Include: Article content Article content Garo H. Armen, PhD Article content Founder, Chairman, CEO of Agenus Article content Jennifer Buell, PhD CEO of MiNK Therapeutics/ Chair of Executive Committee of Agenus Article content Richard M. Goldberg, MD Chief Development Officer of Agenus (joined May 2025) GI oncology expert with 40+ years in CRC research Article content Nicholas C. DeVito, MD Assistant Professor of Medical Oncology at Duke University Primarily treats patients with CRC and gastroesophageal cancers Research focused on tumor immune evasion and immunotherapy Article content Chris O'Callaghan, DVM, MSc, PhD, & Jonathan Loree, MD, MS, FRCPC (CCTG): Senior Investigators at Canadian Cancer Trials Group (CCTG) Stakeholder Briefing Details: Webcast Link | Audience Conference Call Registration Link | Conference ID: 73242 Article content About Agenus Article content Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents. The company was founded in 1994 with a mission to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus has robust end-to-end development capabilities, across commercial and clinical cGMP manufacturing facilities, research and discovery, and a global clinical operations footprint. Agenus is headquartered in Lexington, MA. For more information, visit or @agenus_bio. Information that may be important to investors will be routinely posted on our website and social media channels. Article content About Botensilimab (BOT) Article content Botensilimab is a multifunctional, human Fc enhanced CTLA-4 blocking antibody designed to boost both innate and adaptive anti-tumor immune responses. Its novel design leverages mechanisms of action to extend immunotherapy benefits to 'cold' tumors which generally respond poorly to standard of care or are refractory to conventional PD-1/CTLA-4 therapies and investigational therapies. Botensilimab augments immune responses across a wide range of tumor types by priming and activating T cells, downregulating intratumoral regulatory T cells, activating myeloid cells and inducing long-term memory responses. Article content Botensilimab alone, or in combination with Agenus' investigational PD-1 antibody, balstilimab, has shown clinical responses across nine metastatic, late-line cancers. Approximately 1,200 patients have been treated across the botensilimab/balstilimab program in phase 1 and phase 2 clinical trials. For more information about botensilimab trials, visit Article content About Balstilimab (BAL) Article content Balstilimab is a novel, fully human monoclonal immunoglobulin G4 (IgG4) designed to block PD-1 (programmed cell death protein 1) from interacting with its ligands PD-L1 and PD-L2. It has been evaluated in >900 patients to date and has demonstrated clinical activity and a favorable tolerability profile in several tumor types. Article content Forward-Looking Statements Article content This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding the botensilimab and balstilimab clinical programs, expected trial initiations and regulatory plans, and the potential benefits of the combination therapy. Words such as 'may,' 'believes,' 'expects,' 'anticipates,' 'hopes,' 'intends,' 'plans,' 'forecasts,' 'estimates,' 'will,' 'potential,' 'game-changing,' 'curative,' and similar expressions are intended to identify forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. Factors that could cause actual results to differ include, but are not limited to, those described under the 'Risk Factors' section of Agenus' most recent Annual Report on Form 10-K for 2024 and subsequent Quarterly Reports on Form 10-Q filed with the SEC. Agenus cautions investors not to place undue reliance on forward-looking statements in this release, which speak only as of the date of this announcement. The company undertakes no obligation to update or revise these statements, except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Article content Article content Article content Article content Contacts Article content Investors Article content Article content 917-362-1370 |
Globe and Mail
36 minutes ago
- Globe and Mail
More seniors want to age in place. Here's how technology can help
Betty Falkner's mother didn't want to move into an assisted living home. But by 1994, at age 87, 'she just couldn't be left in the house anymore,' recalls Ms. Falkner. 'She had already fallen once. Her brother had fallen and broken a hip and waited three days [before he was] found. So, she knew the risks of living alone.' Now nearly 80 herself, Ms. Falkner says today's seniors can live at home longer, 'because of all the technology that's helping us stay in our homes. Now, my mother might have a choice. At that time, she really didn't.' Ms. Falkner, a retired accountant, lives with her husband in a bungalow just outside Edmonton. Thanks to technology, she plans to live there for life – a goal shared by many Canadians. In a 2024 federal government study called Supporting Canadians Aging at Home, up to 96 per cent of Canadians aged 65 and older said they would do everything possible to avoid going into a long-term care facility. A few years ago, Ms. Falkner developed a hereditary condition called essential tremor. It caused her hands to shake so severely that daily activities – from writing and brushing her teeth to eating and drinking – became difficult. 'You scrape your gums with your toothbrush,' she says. Dialing a cell phone, fitting a key into a keyhole or cutting food was challenging. Now she uses a 'smart' glove, developed by Toronto startup Steadiwear Inc., to manage her tremors. Designed to stabilize the wrist joint, the glove helps reduce shaking for people with essential tremor or Parkinson's disease. 'I am just thrilled with it,' she says. 'It's made such a difference in my life because I have control of my hands again.' Since her condition can leave her unsteady, Ms. Falkner also uses the Fall Detection feature on her Apple Watch, which can detect hard falls and alert emergency services. Its gait-steadiness feature provides early warnings to help prevent falls. 'If I ever end up by myself,' she says, 'I won't have to leave my home because I know there are so many things available now that would make me feel safe here.' Bridgette Murphy, acting chief executive officer at Age-Well, a national technology and aging network, says Ms. Falkner's Steady-3 glove is among some 180 innovations supported by the organization to help older adults maintain independence, health and quality of life. Since launching a decade ago, Age-Well has partnered with more than 400 industry, academic and government partners. Its collaborations range from smart-home technology and remote monitoring to robotic and AI-driven tools for social connection, cognition and mobility. Canada's age-tech sector is expanding at a critical time, says Ms. Murphy, as nearly nearly one in four Canadians will be aged 65 and older in just five years, in an already stressed health-care system. In 2024, seniors accounted for nearly half of all health-care spending, according to Canadian Institute for Health Information. Per capita, spending on seniors was five times higher than for those under age 65. Yet studies show that up to 22 per cent of hospital visits by seniors could be avoided through better health management that technology can enable. 'When you've got a health-care system that can't take much more pressure and individuals who would rather not be in it, there's a clear pathway for technology to help keep costs down and improve quality of life,' says Ms. Murphy. Although older adults are often stereotyped as technophobic, nine in 10 use the internet daily, and 80 per cent say they're confident that technological advancements can help them stay safe, independent and at home longer. But how can seniors find out about innovations like wearable airbags that prevent hip injury, social robots that promote connection or smart fridges that analyze grocery needs? Enter Age-Well's Innovation Studio. Located in Toronto and modelled after a typical one-bedroom apartment for seniors, the studio integrates Canadian-made technologies designed to support daily activities and health-care needs. Ms. Falkner attended the studio's opening event in May, demonstrating her glove and learning about other innovations, such as Quantum Robotic Systems' QBii robot, which carries heavy loads around the house and up and down stairs; TochTech Technologies Ltd.'s smart stove monitor which sends alerts if a stove is left unattended; and Centivizer's virtual biking experience. From an armchair or wheelchair, users can pedal a stationary pedal system, while watching travel videos on screen. The catch? They have to keep pedalling to view the footage – turning exercise into a rewarding experience. Since half of Canadians will be caregivers at some point in their lives, the Innovation Studio also features tech solutions for those who care for seniors. Among them are remote monitoring systems from AltumView and Chirp that detect human activity and send alerts in emergencies such as falls. Unlike traditional surveillance, both are designed to protect privacy. AltumView's video feed scrambles human images into stick figures, while Chirp uses radar, thermal and audio sensors instead of video. Both systems use AI-powered apps that detect early signs of health decline – for example, if a senior stays in bed longer than usual, an alert is sent so care providers can intervene sooner. R. Bruce Wallace, an Ottawa-based professor and engineer, develops solutions for seniors with mobility and memory disability, as well as for caregivers, who are often overwhelmed by the demands of balancing caregiving with their own lives. 'We have to account for both these individuals,' says Dr. Wallace, executive director of the Age-Well National Innovation Hub on Sensors and Analytics for Monitoring Mobility and Memory (SAM3), a collaboration between the Bruyère Health Research Institute and Carleton University in partnership with Age-Well. 'If you're the spouse or the adult child taking care of someone living with dementia, you go to bed every night with one eye open. And if you don't get enough sleep, you burn out.' At the start of the pandemic, Dr. Wallace moved more than 100 sensors from his labs to his home, turning it into a smart-home testing site. Sensors on his fridge, stove, mattress, floors and doors track everything from eating and sleeping patterns to gait and movement. If someone gets out of bed and doesn't return within a set time or if an exterior door opens in the night, the system sends an alert to the caregiver. Dr. Wallace says the system allows caregivers to sleep easier, knowing there's a protective layer of technology in place. The equipment is relatively inexpensive, he adds. 'It's mostly the same hardware used for home security systems. We're just turning it on its head.' He expects this kind of technology will become more common in homes with seniors with dementia in the coming years. 'We have a baby boomer issue,' he explains. 'If boomers are institutionalized at the same rate as their parents, we don't have enough long-term care beds.' The alternative puts the burden on family members or other caregivers, he adds. 'So, I see technology as a way to offload that work – helping people support seniors and still do everything else they need to do.' Ms. Murphy agrees. 'A lot of caregivers are older adults themselves. The roles are sometimes fluid. So, it's important to consider holistically what it means to age in place. It's not just about the individual – it's their environment, their social circle and their circle of care. 'Technology isn't the only solution,' she adds, 'but it can be harnessed to support people remain where they want to remain as they age.'
